Tech Company Financing Transactions
MabVax Therapeutics Funding Round
MabVax Therapeutics closed a $5.3 million funding round on 11/23/2012. Investors included Numoda Capital Innovations, Burrill & Company and RTP Ventures.
Transaction Overview
Company Name
Announced On
11/23/2012
Transaction Type
Venture Equity
Amount
$5,250,000
Round
Undisclosed
Investors
Proceeds Purpose
The additional capital will allow MabVax to continue the development of its phase 2 vaccine aimed at preventing recurrent sarcoma and its 5B1 antibody program targeting metastatic pancreatic cancer.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
11535 Sorrento Valley Rd. 400
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
MabVax Therapeutics, Inc. is a San Diego, California based immunotherapeutics discovery and development company focused on developing and commercializing novel vaccines and human antibodies for the treatment of cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Hansen
Chief Financial Officer
Gregory Hanson
Chief Scientific Officer
Philip Livingston
Vice President
Wolfgang Scholz
VP - Bus. Development
Paul Resnick
VP - R & D
Paul Maffuid
Browse more venture capital transactions:
Prev: 11/23/2012: Nearbuy Systems venture capital transaction
Next: 11/23/2012: Lattice Engines venture capital transaction
Share this article
About Database of VC Transactions
We report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs